Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-03-2024 | Losartan | Case report

Aspirin/Losartan

Lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Joshi E, et al. Alprostadil in treatment of persistent raynauds phenomenon associated with systemic sclerosis. Indian Journal of Rheumatology 18 (Suppl. 2): S366 abstr. CAS134, Jan 2023. Available from: URL: https://dx.doi.org/10.4103/0973-3698.393684 [abstract] Joshi E, et al. Alprostadil in treatment of persistent raynauds phenomenon associated with systemic sclerosis. Indian Journal of Rheumatology 18 (Suppl. 2): S366 abstr. CAS134, Jan 2023. Available from: URL: https://dx.doi.org/10.4103/0973-3698.393684 [abstract]
Metadata
Title
Aspirin/Losartan
Lack of efficacy
Publication date
01-03-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54749-9

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Cemiplimab

Case report

Tocilizumab

Case report

Antineoplastics